Released May 9, 2017, after the close
10-Q filed May 9, 2017, 39 days after period end · 0001162194-17-000042
Q1 2017 · 10-Q
Revenue$25.53M$25.53M −12.0% vs Q1 2016+1.8% vs Q4 2016
Net Income-$17.20M-$17.20M N/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$0.59-$0.59 N/M vs Q1 2016N/M vs Q4 2016
Operating Income-$17,536,000N/M
Operating Cash Flow-$8,488,000N/M
Free Cash Flowderived-$9,180,000N/M
Margins · derived
Operating margin-68.7%−3.6 pt vs Q1 2016
Net margin-67.4%+1.2 pt vs Q1 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $25.53M | $29.00M | $26.73M | $25.72M |
| Net Income | -$17.20M | -$19.88M | -$15.93M | -$15.41M |
| EPS Diluted | -$0.59 | -$0.69 | -$0.56 | -$0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR